At Broadstreet we deliver solutions not formulas.
An open-minded and client-focused approach means we can customize our process to your needs.
Broadstreet is a boutique health economics and outcomes research consultancy founded on the idea that good research begins with a solid client-consultant relationship. We consistently deliver high-quality products for two key reasons.
We only take on work we know we’re great at and, more importantly, we put the client at the center of the process.
Epidemiology & Observational Studies
Our team designs and conducts observational studies used to characterize the clinical landscape and burden of disease for a product’s indication; estimate treatment effectiveness or safety; or parameterize economic models.
We provide rigorously conducted literature reviews following best practice guidelines, coupled with robust quantitative or qualitative evidence syntheses, to address a variety of research questions.
Our team develops HEOR models for a variety of contexts and settings. Our approach to model development and adaptation is to work with clients to design a customized structure and interface, in accordance with submission requirements and guidelines for best practice.
HEOR Technology Services
We have the IT capability to undertake big solutions. This comes from our longstanding relationship with an IT partner that allows us to create high-quality solutions for our clients for timely data collection, and novel tools for dissemination of study findings.
Broadstreet is off to Barcelona for this year’s ISPOR Europe conference, November 10th to 14th. We’ll be more than happy to spend a few days taking in Gaudí’s architectural marvels, eating tiny sandwiches, drinking coffees in leafy squares…and of course, […]
Broadstreet presents a new method for reconstructing individual patient data from Kaplan-Meier curves
Broadstreet team member, Basia Rogula (Senior Statistician), was at the 40th Annual North American meeting of the Society for Medical Decision Making in Montreal this week to present a novel method we have developed for reconstructing individual patient data […]
Yesterday, Broadstreet’s Karissa Johnston was asked by the CBC to comment on a new study that suggested that some commonly prescribed drugs could have adverse events leading to depression or even suicide. The study (which nether Karissa nor Broadstreet were […]